Analysis of Terpenes in Cannabis sativa L. Using GC/MS: Method Development, Validation, and Application
暂无分享,去创建一个
Safwat Ahmed | I. Khan | A. Ibrahim | M. Elsohly | M. Radwan | Yan-Hong Wang | Mei Wang | H. Lata | E. Ibrahim | G. Hadad | S. Chandra | Randa A Abdel Salam | C. G. Majumdar | A. Wanas | R. A. Abdel Salam | B. Avula | Ghada M. Hadad
[1] M. Wallace,et al. Medical Cannabis for Neuropathic Pain , 2018, Current Pain and Headache Reports.
[2] Ghada M Hadad,et al. Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of Cannabis sativa Using GC-FID , 2017, Planta Medica.
[3] Mike West,et al. Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to Supercritical CO2 Concentrate , 2017, Planta Medica.
[4] L. Amato,et al. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy]. , 2017, Epidemiologia e prevenzione.
[5] T. Rudroff,et al. Cannabis and Multiple Sclerosis—The Way Forward , 2017, Front. Neurol..
[6] A. Hazekamp,et al. Cannabis: From Cultivar to Chemovar II—A Metabolomics Approach to Cannabis Classification , 2016 .
[7] Mellar P. Davis. Cannabinoids for Symptom Management and Cancer Therapy: The Evidence. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.
[8] Y. Gabet,et al. The skeletal endocannabinoid system: clinical and experimental insights , 2016, Journal of basic and clinical physiology and pharmacology.
[9] O. B. Yosef,et al. CBD-enriched medical cannabis for intractable pediatric epilepsy The current Israeli experience , 2016, Seizure.
[10] B. Wilsey,et al. Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. , 2015, The journal of pain : official journal of the American Pain Society.
[11] Matthew W Giese,et al. Development and Validation of a Reliable and Robust Method for the Analysis of Cannabinoids and Terpenes in Cannabis. , 2015, Journal of AOAC International.
[12] Safwat Ahmed,et al. Minor oxygenated cannabinoids from high potency Cannabis sativa L. , 2015, Phytochemistry.
[13] J. Fischedick,et al. Cannabinoids and Terpenes as Chemotaxonomic markers in Cannabis , 2015, Prime Archives in Chemistry.
[14] K. Hill. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. , 2015, JAMA.
[15] Penny F Whiting,et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. , 2015, JAMA.
[16] Lisa Wilson,et al. Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. , 2015, Journal of natural products.
[17] C. Siegel,et al. Medical Marijuana for Digestive Disorders: High Time to Prescribe? , 2015, The American Journal of Gastroenterology.
[18] L. Dujourdy,et al. Multidimensional analysis of cannabis volatile constituents: identification of 5,5-dimethyl-1-vinylbicyclo[2.1.1]hexane as a volatile marker of hashish, the resin of Cannabis sativa L. , 2014, Journal of chromatography. A.
[19] R. Pertwee. Handbook of Cannabis , 2014 .
[20] C. Porto,et al. Separation of aroma compounds from industrial hemp inflorescences (Cannabis sativa L.) by supercritical CO2 extraction and on-line fractionation , 2014 .
[21] Benjamin J. Whalley,et al. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders , 2014, Epilepsia.
[22] O. Devinsky,et al. The case for assessing cannabidiol in epilepsy , 2014, Epilepsia.
[23] B. Pradier,et al. The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain , 2014, European Neuropsychopharmacology.
[24] J. Amigo,et al. Resolution of co-eluting compounds of Cannabis Sativa in comprehensive two-dimensional gas chromatography/mass spectrometry detection with Multivariate Curve Resolution-Alternating Least Squares. , 2014, Talanta.
[25] M. Michelozzi,et al. Variations in terpene profiles of different strains of Cannabis sativa L , 2011 .
[26] Ethan B. Russo. Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects , 2011, British journal of pharmacology.
[27] Andrea Monti,et al. Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.). , 2010, Fitoterapia.
[28] Xiang-Qun Xie,et al. Beta-caryophyllene is a dietary cannabinoid , 2008, Proceedings of the National Academy of Sciences.
[29] R. Verpoorte,et al. Secondary metabolism in cannabis , 2008, Phytochemistry Reviews.
[30] M. Miyazawa,et al. Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids. , 2005, Journal of agricultural and food chemistry.
[31] F. Grotenhermen. Pharmacology of cannabinoids. , 2004, Neuro endocrinology letters.
[32] G. Lockwood. Techniques for gas chromatography of volatile terpenoids from a range of matrices. , 2001, Journal of chromatography. A.
[33] P. Robson,et al. Prospects for New Cannabis-Based Prescription Medicines , 2001 .
[34] M. Careri,et al. Gas Chromatography-Mass Spectrometry Analysis of Flavors and Fragrances , 2001 .
[35] C. Rustichelli,et al. Analytical characterisation of hashish samples , 2000 .
[36] A. Hazekamp,et al. Cannabis: From Cultivar to Chemovar II—A Metabolomics Approach to Cannabis Classification , 2016 .
[37] J. McPartland,et al. Non-Phytocannabinoid Constituents of Cannabis and Herbal Synergy , 2014 .
[38] Arno Hazekamp,et al. Cannabis Oil: chemical evaluation of an upcoming cannabis-based medicine , 2013 .
[39] R. Jubb,et al. PATIENTS AND METHODS , 1982 .
[40] D. Pustaka,et al. Guidelines for single laboratory validation of chemical methods for dietary supplements and botanicals , 2005 .
[41] G. Guy,et al. The development of Sativex® — a natural cannabis-based medicine , 2005 .